Microbot Medical (MBOT) Shares Outstanding (Weighted Average) (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $67.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 116.04% year-over-year to $67.2 million; the trailing twelve-month figure through Mar 2026 stood at $67.2 million (up 116.04% YoY), and the FY2025 full-year result was $45.8 million, up 781.88% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $67.2 million, up from $16.3 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $67.2 million in Q1 2026 and bottomed at $60476.0 in Q4 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $9.7 million (2023), against an average of $17.7 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) slumped 99.17%; it then surged 8485.78% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $7.3 million in 2022, then plunged by 99.17% to $60476.0 in 2023, then soared by 8485.78% to $5.2 million in 2024, then surged by 214.17% to $16.3 million in 2025, then surged by 311.68% to $67.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $67.2 million (Q1 2026), $16.3 million (Q4 2025), and $48.1 million (Q3 2025), per Business Quant data.

Peer Comparison